Shares of agilon health, inc. (NYSE:AGL) have received an average rating of “Buy” from the thirteen brokerages that are currently covering the company, MarketBeat.com reports. One equities research analyst has rated the stock with a sell recommendation and twelve have given a buy recommendation to the company. The average 1-year price target among analysts that have issued ratings on the stock in the last year is $38.18.
A number of research firms recently weighed in on AGL. Jefferies Financial Group assumed coverage on agilon health in a research note on Wednesday, October 20th. They issued a “buy” rating and a $35.00 price target on the stock. SVB Leerink reduced their target price on agilon health from $37.00 to $35.00 and set an “outperform” rating on the stock in a report on Monday, November 1st. Zacks Investment Research lowered agilon health from a “hold” rating to a “sell” rating in a report on Wednesday, December 29th. Truist reduced their target price on agilon health from $41.00 to $35.00 and set a “buy” rating on the stock in a report on Wednesday, October 13th. Finally, Truist Securities reduced their target price on agilon health from $41.00 to $35.00 and set a “buy” rating on the stock in a report on Wednesday, October 13th.
In other news, insider Joan Danieley sold 3,519 shares of the firm’s stock in a transaction dated Thursday, December 16th. The stock was sold at an average price of $23.14, for a total transaction of $81,429.66. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Theodore Halkias sold 5,583 shares of the firm’s stock in a transaction dated Monday, December 27th. The stock was sold at an average price of $27.53, for a total value of $153,699.99. The disclosure for this sale can be found here. Insiders sold 189,914 shares of company stock valued at $4,846,156 over the last quarter.
Shares of agilon health stock opened at $19.61 on Friday. agilon health has a 12-month low of $18.55 and a 12-month high of $44.83. The company has a current ratio of 3.44, a quick ratio of 3.44 and a debt-to-equity ratio of 0.04. The business’s 50 day moving average is $24.07 and its 200-day moving average is $29.16.
agilon health (NYSE:AGL) last announced its quarterly earnings data on Wednesday, October 27th. The company reported ($0.09) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.07) by ($0.02). agilon health had a negative return on equity of 26.63% and a negative net margin of 22.11%. The company had revenue of $458.61 million for the quarter, compared to the consensus estimate of $452.54 million. On average, equities research analysts expect that agilon health will post -1.03 EPS for the current year.
agilon health Company Profile
agilon health, inc. offers healthcare services for seniors through primary care physicians in the communities of the United States. The company was formerly known as Agilon Health Topco, Inc and changed its name to agilon health, inc. in March 2021. The company was founded in 2016 and is based in Long Beach, California.
See Also: What is a Market Correction?
Receive News & Ratings for agilon health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for agilon health and related companies with MarketBeat.com's FREE daily email newsletter.